Frequency-specific microcurrent

01Key questions

02Overview

Frequency-specific microcurrent (FSM) is a subset of microcurrent electrical stimulation that applies microampere-level current through two channels, each carrying selected frequency patterns. Practitioners claim that one channel encodes a tissue or organ target and the other encodes a condition or pathology. This claim is more specific than the general bioelectric rationale for microcurrent and should be treated with more skepticism.

The most defensible framing is:

1. Microcurrent itself is biologically plausible because tissues generate endogenous electrical fields during development and repair.
2. Wound-healing microcurrent has human RCT evidence, including a 2022 meta-analysis of randomized clinical trials (PMID: 34903470).
3. FSM frequency-pair specificity is less proven; current evidence is a mix of small studies, mechanistic hypotheses, clinical case reports, and practitioner experience.
4. Risk is usually low when used conservatively, but devices and protocols vary widely, and claims often outrun data.

Related files: Electromagnetic Therapies, Overview - Regenerative Medicine, Peptide Therapy for Injuries, Overview - Photobiomodulation, Mitochondrial Health.

03Definitions

Microcurrent

Microcurrent electrical therapy generally uses currents in the microampere range, often ~10–1,000 μA. Unlike TENS, which is usually felt as tingling or muscle stimulation, microcurrent is commonly sub-sensory.

Frequency-Specific Microcurrent

FSM usually refers to a clinical system popularized by Carolyn McMakin and colleagues. It combines:

• Microampere current rather than milliampere TENS intensity
• Two-channel frequency pairs rather than one generic pulse setting
• Condition/tissue frequency tables derived largely from historical practice and clinician observation
• Hands-on application with graphite gloves, wet towels, or adhesive electrodes

Bioelectricity

Bioelectricity is not mystical: ion gradients, membrane potentials, endogenous wound currents, epithelial voltage gradients, and injury potentials are measurable biological phenomena. The contested part is whether externally applied consumer or clinic devices can reliably reproduce useful, tissue-specific instructions.

04Mechanisms of Action

1. Endogenous Wound Currents

Injury disrupts epithelial barriers and creates local electric fields. Cells involved in repair — keratinocytes, fibroblasts, macrophages, endothelial cells — can respond to electric-field direction and intensity. A conservative hypothesis is that microcurrent augments or organizes these weak repair signals.

2. Cell Membrane and Ion Channel Effects

Low-level electrical stimulation can plausibly influence membrane potential, calcium flux, ATP demand, and nitric-oxide-related vascular tone. This does not require accepting the strongest FSM claims about exact disease frequencies; it only requires that cells are electrically excitable and electrochemically organized.

3. ATP and Protein Synthesis Claims

A frequently cited older experiment by Cheng et al. reported increased ATP generation, amino-acid transport, and protein synthesis in rat skin exposed to low-level current. This study is often quoted in marketing as “ATP increases 300–500%.” Useful caveats:

• It was preclinical, not a human outcome trial.
• Effects depended on current intensity; more current was not automatically better.
• The finding supports plausibility, not universal clinical efficacy.

4. Anti-Inflammatory Signaling

Small FSM studies and practitioner reports often focus on rapid pain reduction and tissue softening. Possible non-exclusive explanations:

• reduced sympathetic tone
• local vasodilation and improved perfusion
• altered inflammatory mediators
• descending pain modulation
• placebo/contextual effects from a relaxing hands-on session

5. Fascia, Tone, and “Tissue Softening”

McMakin and Oschman describe rapid palpable tissue softening and warming during FSM sessions (PMID: 22775307; PMCID: PMC3576917). This is clinically interesting but mechanistically unresolved. The phenomenon could reflect changes in muscle tone, autonomic state, local fluid dynamics, practitioner perception, or some combination.

05Evidence at a Glance

Swipe table →

06Key Human Studies

Delayed-Onset Muscle Soreness RCT

Curtis et al. tested FSM after eccentric hamstring exercise in 35 healthy participants (PMID: 20538225). One leg received 20 minutes of FSM and the other leg served as control. Reported soreness was much lower in the treated leg:

Swipe table →

Interpretation: The effect size is striking, but the model is acute exercise soreness in healthy volunteers. It does not automatically generalize to tendon tears, neuropathy, chronic pain syndromes, or systemic inflammatory disease.

Wound Healing Meta-Analysis

A 2022 meta-analysis of randomized clinical trials examined electrical microcurrent therapy for acute and chronic wounds (PMID: 34903470). It included 8 RCTs qualitatively and 7 in quantitative analysis, with 337 total participants. Compared with standard wound care alone, microcurrent plus standard wound care improved:

• Wound surface area: mean difference −8.3 cm², 95% CI −10.5 to −6.0
• Healing time: mean difference −7.0 days, 95% CI −11.9 to −2.1
• Pain: mean difference −1.4 points, 95% CI −2.7 to −0.2

The authors rated certainty as moderate for wound surface reduction, low for healing time, and very low for number of wounds healed.

Palatal Wound Healing RCT

A double-masked randomized clinical trial of 53 patients after free gingival graft harvest found that microcurrent electrotherapy accelerated palatal wound closure and epithelialization, reduced pain at 3 days, and improved early oral-health quality-of-life scores (PMID: 32783220).

Interpretation: This supports microcurrent as a wound-healing adjunct in a defined surgical injury model. It does not prove FSM's frequency-pair theory.

Systemic Sclerosis / Raynaud's Pilot Studies

Gregory et al. reported two pilot studies of FSM in 17 systemic sclerosis patients with hand dysfunction and Raynaud's symptoms (PMID: 40465410). After 45–60 minutes of treatment over 1–2 days, hand function improved ~40% in combined analyses and Raynaud's VAS improved 18/100 points.

Interpretation: The rapid effect is notable and biologically plausible if vascular tone or soft tissue stiffness changed, but the study was small and not definitive. It is best treated as a signal for sham-controlled trials.

07Practical Notes

General Session Parameters

Typical clinical microcurrent/FSM sessions use:

Swipe table →

Conservative Trial Framework

For self-experimentation or clinic evaluation, use an N-of-1 structure:

1. Define one target outcome — pain VAS, range of motion, wound size, grip strength, sleep disruption, HRV.
2. Collect baseline for 3–7 days when possible.
3. Keep other interventions stable — avoid adding BPC-157 (Body Protection Compound), Overview - Photobiomodulation, sauna, or new supplements simultaneously.
4. Use sham/blinding if possible — e.g., have someone else set active/sham sessions when the device permits.
5. Track durability — immediate pain relief is less meaningful than retained function over days/weeks.
6. Stop for adverse reactions — unusual pain flares, skin irritation, palpitations, dizziness, or neurological symptoms.

Possible Use Cases

Most plausible:

• post-procedure wound discomfort
• delayed-onset muscle soreness
• chronic wounds under professional care
• localized soft tissue pain where TENS is too stimulating
• adjunct to rehab when pain blocks movement

More speculative:

• fibromyalgia and central sensitization
• Raynaud's / vasospasm syndromes
• scar remodeling
• neuropathic pain
• visceral conditions claimed by FSM practitioners

Contraindications and Cautions

Avoid or use only with qualified clinical guidance in:

• implanted electrical devices such as pacemakers or defibrillators
• pregnancy, especially over abdomen/pelvis
• active malignancy over treatment area unless oncology team approves
• seizure disorders if applying near head/neck
• broken skin unless device/protocol is intended for wound care
• acute infection where delayed medical treatment would be dangerous

Microcurrent should not substitute for urgent care in fracture, deep infection, tendon rupture, ischemia, progressive neurological deficit, or non-healing ulcers.

08Relationship to Other Regenerative Modalities

Compared with TENS

TENS is primarily analgesic and usually uses milliampere currents that the patient can feel. Microcurrent is lower intensity and is framed as reparative rather than only analgesic. In practice, both may reduce pain; the distinction matters because pain relief is not the same as tissue healing.

Compared with PEMF

PEMF induces electrical fields magnetically and can reach deeper tissues without skin electrodes. Microcurrent passes current through surface contact points. PEMF has stronger regulatory history for bone non-unions; microcurrent has a more wound-focused evidence base.

Compared with Photobiomodulation

Photobiomodulation targets cytochrome c oxidase and redox signaling using light. Microcurrent targets electrical gradients and membrane signaling. Both are low-energy modalities with plausible mitochondrial links and both suffer from heterogeneous device parameters.

Compared with Peptides

Peptide Therapy for Injuries attempts to alter repair signaling chemically. Microcurrent attempts to alter repair signaling electrically. Combining them may make sense mechanistically, but stacking interventions makes it difficult to know what worked.

09Critical Analysis

What Seems Real

• Endogenous electrical fields participate in wound healing.
• Microcurrent has RCT-level support as an adjunct for some wound-healing contexts.
• At least one FSM DOMS study showed large short-term effects.
• Low-intensity electrical therapies are underexplored partly because they do not fit the pharmaceutical IP/reimbursement model.

What Remains Unproven

• Whether FSM frequency tables correspond to objective tissue/pathology resonances.
• Whether rapid tissue softening predicts durable healing.
• Which frequencies, currents, waveforms, and placements are necessary versus ritualized practitioner tradition.
• Whether benefits exceed contextual/placebo effects for chronic pain conditions.

Red Flags in the Field

• claims to cure cancer, Lyme, autism, or chronic infections without controlled data
• proprietary frequency lists treated as secret knowledge rather than testable hypotheses
• lack of published parameters, making replication impossible
• selling expensive devices while citing only preclinical ATP claims
• using symptom relief as proof of structural repair

10Research Leads

• Replicate the DOMS study with sham control, concealed allocation, and objective markers such as creatine kinase, force recovery, ultrasound elastography, and inflammatory cytokines.
• Run a randomized sham-controlled FSM trial for Raynaud's with digital perfusion imaging and cold challenge.
• Compare generic microcurrent vs FSM frequency pairs to test whether the frequency-specific component adds anything.
• Standardize reporting: waveform, current, frequency, electrode placement, tissue impedance, treatment duration, and co-interventions.
• Examine whether microcurrent synergizes with Overview - Photobiomodulation or Hyperbaric Oxygen Therapy in wound models.

11Notes

• The library should eventually separate generic microcurrent electrical stimulation from FSM if enough material accumulates. Right now they are combined because much of the practical overlap is device/protocol-based.
• The strongest current evidence is for wound-healing adjunct use, not for broad chronic disease claims.
• The most important unresolved question is whether specific frequency pairs add benefit beyond low-level electrical stimulation plus practitioner attention.
• Future update: retrieve full-text protocol parameters from the wound-healing RCTs and add a parameter comparison table.

Related: Electromagnetic Therapies | Overview - Regenerative Medicine | Peptide Therapy for Injuries | Overview - Photobiomodulation | Mitochondrial Health | Hyperbaric Oxygen Therapy

12Connections

13Sources

1. Poltawski L, et al. Electrical microcurrent stimulation therapy for wound healing: A meta-analysis of randomized clinical trials. J Tissue Viability. 2022. PMID: 34903470 .PubMed 34903470
2. McMakin CR, Oschman JL. Visceral and somatic disorders: tissue softening with frequency-specific microcurrent. J Altern Complement Med. 2013;19(2):170-177. PMID: 22775307 . PMCID: PMC3576917 .PubMed 22775307 · PMC3576917
3. Krey AO, et al. Microcurrent electrotherapy improves palatal wound healing: randomized clinical trial. J Periodontol. 2021. PMID: 32783220 .PubMed 32783220
4. Curtis D, Fallows S, Morris M, McMakin C. The efficacy of frequency specific microcurrent therapy on delayed onset muscle soreness. J Bodyw Mov Ther. 2010;14(3):272-279. PMID: 20538225 .PubMed 20538225
5. Gregory WM, Bagley K, Eng S, McMakin C, Del Galdo F. Frequency-specific microcurrent improves hand function and Raynaud's symptoms in scleroderma: results of two pilot studies. Rheumatology (Oxford). 2025. PMID: 40465410 .PubMed 40465410

14Entry history

Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.